AGP Executive Report
Last update: 2 hours agoCardiology Breakthrough: Denmark-led REACT research at ESC 2026 finds silent atherosclerosis is widespread from early adulthood—57.1% of 16,808 symptom-free adults had plaques, with sex-specific growth patterns—suggesting today’s risk tools may miss many people who could benefit from earlier prevention. Heart Failure Implementation: The EMAIL-HF trial reports a nationwide digital registry approach that more than doubled uptake of effective SGLT2 inhibitor treatment for untreated heart failure patients via telephone follow-up. Diabetes & Cardiovascular Risk: The US FDA expanded Eli Lilly’s Mounjaro (tirzepatide) to reduce heart attack and stroke risk in high-risk adults with type 2 diabetes. Infective Endocarditis Treatment: POET-II shows response-tailored antibiotics can cut left-sided infective endocarditis treatment duration by about one-third (41 to 26 days) without compromising overall safety. Reproductive Rights in Greenland: Greenland says it cannot yet conclude whether Denmark’s forced contraception campaign meets the legal definition of genocide, though expert reports agree women’s rights were violated. Public Health & Migration: Rwanda is in talks with several European countries about becoming transit hubs for rejected migrants, including Denmark, according to Rwanda’s government.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
